Qualitative study of patients experiences and perceptions of stepping down asthma medication in primary care across England
Qualitative study of patients experiences and perceptions of stepping down asthma medication in primary care across England
Background: guidelines recommend that asthma medication should be stepped down to the minimally effective dose that achieves symptom control. Stepping down aims to prevent adverse medication effects and unnecessary costs but is often not implemented in primary care, where most asthma patients are managed. Little is known about the experiences and views of patients regarding stepping down.
Methods: stable asthma patients, with regular use of a preventer inhaler, from GP practices across England, participated in a survey and/or semi-structured interview. Questions explored the patient’s understanding of their asthma, views and knowledge of preventer inhalers, experiences and perceptions of stepping down asthma medication. Qualitative group-based multi-disciplinary thematic analysis by two healthcare professionals and a patient were performed.
Results: 143 patients responded to the survey, 63% were female, between the ages 18-80 years, and including geographical areas across the UK, 17 of whom participated in an interview. Half of these stable asthma patients, most with asthma for more than 10 years, had never had a discussion regarding stepping down asthma medication. Most stepping down that had occurred was related to seasonal changes in asthma control. Four overarching themes from the interviews were identified, (i) experiences of living with asthma and needing inhalers, (ii) insufficient education regarding preventer inhalers, (ii) stepping down is agreeable and possible and (iv) current asthma care is suboptimal.
Conclusion: stable asthma patients were able to self-manage their asthma well. They had little awareness of medication adverse effects and minimal experience of having their medication stepped down by a healthcare professional. Most were inclined to step down, if clinically safe to do so, indeed some had reduced their medication doses themselves, without professional guidance.
Bloom, Chloe I.
b3130100-2316-417f-a333-b01790815b7b
Middleton, Jack
441bc5f5-14a7-4a0f-964f-f0f5358661b4
Lewis, Adam
71c83b66-d847-4aee-b716-b04d6de51450
Bloom, Chloe I.
b3130100-2316-417f-a333-b01790815b7b
Middleton, Jack
441bc5f5-14a7-4a0f-964f-f0f5358661b4
Lewis, Adam
71c83b66-d847-4aee-b716-b04d6de51450
Bloom, Chloe I., Middleton, Jack and Lewis, Adam
(2024)
Qualitative study of patients experiences and perceptions of stepping down asthma medication in primary care across England.
BMJ Open Respiratory Research.
(doi:10.1136/bmjresp-2024-002898).
(In Press)
Abstract
Background: guidelines recommend that asthma medication should be stepped down to the minimally effective dose that achieves symptom control. Stepping down aims to prevent adverse medication effects and unnecessary costs but is often not implemented in primary care, where most asthma patients are managed. Little is known about the experiences and views of patients regarding stepping down.
Methods: stable asthma patients, with regular use of a preventer inhaler, from GP practices across England, participated in a survey and/or semi-structured interview. Questions explored the patient’s understanding of their asthma, views and knowledge of preventer inhalers, experiences and perceptions of stepping down asthma medication. Qualitative group-based multi-disciplinary thematic analysis by two healthcare professionals and a patient were performed.
Results: 143 patients responded to the survey, 63% were female, between the ages 18-80 years, and including geographical areas across the UK, 17 of whom participated in an interview. Half of these stable asthma patients, most with asthma for more than 10 years, had never had a discussion regarding stepping down asthma medication. Most stepping down that had occurred was related to seasonal changes in asthma control. Four overarching themes from the interviews were identified, (i) experiences of living with asthma and needing inhalers, (ii) insufficient education regarding preventer inhalers, (ii) stepping down is agreeable and possible and (iv) current asthma care is suboptimal.
Conclusion: stable asthma patients were able to self-manage their asthma well. They had little awareness of medication adverse effects and minimal experience of having their medication stepped down by a healthcare professional. Most were inclined to step down, if clinically safe to do so, indeed some had reduced their medication doses themselves, without professional guidance.
Text
Quali_paper_stepping_down_patients_UNMARKED
- Accepted Manuscript
More information
Accepted/In Press date: 5 December 2024
Identifiers
Local EPrints ID: 497417
URI: http://eprints.soton.ac.uk/id/eprint/497417
ISSN: 2052-4439
PURE UUID: e094801d-8edd-426a-97b5-1f29996c4403
Catalogue record
Date deposited: 22 Jan 2025 17:46
Last modified: 22 Aug 2025 02:42
Export record
Altmetrics
Contributors
Author:
Chloe I. Bloom
Author:
Jack Middleton
Author:
Adam Lewis
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics